Annual CAPEX
N/A
December 31, 2023
Summary
- FRTX annual capital expenditures is not available.
Performance
FRTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
December 31, 2023
Summary
- FRTX quarterly capital expenditures is not available.
Performance
FRTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
December 31, 2023
Summary
- FRTX TTM capital expenditures is not available.
Performance
FRTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
FRTX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
FRTX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Fresh Tracks Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $47.00 K(+30.6%) | $0.00(-100.0%) | $47.00 K(0.0%) |
| Sep 2022 | - | $47.00 K(>+9900.0%) | $47.00 K(+30.6%) |
| Dec 2021 | $36.00 K(+56.5%) | - | - |
| Dec 2021 | - | $0.00(0.0%) | $36.00 K(0.0%) |
| Sep 2021 | - | $0.00(-100.0%) | $36.00 K(0.0%) |
| Jun 2021 | - | -$4000.00(-110.0%) | $36.00 K(-10.0%) |
| Mar 2021 | - | $40.00 K(-4100.0%) | $40.00 K(+471.4%) |
| Dec 2020 | $23.00 K(+228.6%) | - | - |
| Dec 2019 | $7000.00(-80.6%) | -$1000.00(-112.5%) | $7000.00(-22.2%) |
| Sep 2019 | - | $8000.00(-500.0%) | $9000.00(-55.0%) |
| Jun 2019 | - | -$2000.00(-200.0%) | $20.00 K(-47.4%) |
| Mar 2019 | - | $2000.00(+100.0%) | $38.00 K(+5.6%) |
| Dec 2018 | $36.00 K(-55.0%) | $1000.00(-94.7%) | $36.00 K(-59.1%) |
| Sep 2018 | - | $19.00 K(+18.8%) | $88.00 K(+14.3%) |
| Jun 2018 | - | $16.00 K(-69.8%) | $77.00 K(-3.8%) |
| Dec 2017 | $80.00 K(-68.6%) | $53.00 K(+562.5%) | $80.00 K(+53.8%) |
| Sep 2017 | - | $8000.00(+60.0%) | $52.00 K(-24.6%) |
| Jun 2017 | - | $5000.00(-64.3%) | $69.00 K(-61.2%) |
| Mar 2017 | - | $14.00 K(-44.0%) | $178.00 K(-30.2%) |
| Dec 2016 | $255.00 K(+104.0%) | $25.00 K(0.0%) | $255.00 K(+4.5%) |
| Sep 2016 | - | $25.00 K(-78.1%) | $244.00 K(-3.2%) |
| Jun 2016 | - | $114.00 K(+25.3%) | $252.00 K(+54.6%) |
| Mar 2016 | - | $91.00 K(+550.0%) | $163.00 K(+30.4%) |
| Dec 2015 | $125.00 K(-64.7%) | $14.00 K(-57.6%) | $125.00 K(-31.3%) |
| Sep 2015 | - | $33.00 K(+32.0%) | $182.00 K(-16.1%) |
| Jun 2015 | - | $25.00 K(-52.8%) | $217.00 K(-22.2%) |
| Mar 2015 | - | $53.00 K(-25.4%) | $279.00 K(-21.2%) |
| Dec 2014 | $354.00 K(-52.4%) | $71.00 K(+4.4%) | $354.00 K(+2.6%) |
| Sep 2014 | - | $68.00 K(-21.8%) | $345.00 K(-27.2%) |
| Jun 2014 | - | $87.00 K(-32.0%) | $474.00 K(-20.7%) |
| Mar 2014 | - | $128.00 K(+106.5%) | $598.00 K(-19.6%) |
| Dec 2013 | $744.00 K(-29.5%) | $62.00 K(-68.5%) | $744.00 K(-16.4%) |
| Sep 2013 | - | $197.00 K(-6.6%) | $890.00 K(-0.9%) |
| Jun 2013 | - | $211.00 K(-23.0%) | $898.00 K(-18.1%) |
| Mar 2013 | - | $274.00 K(+31.7%) | $1.10 M(+4.0%) |
| Dec 2012 | $1.05 M(+59.4%) | $208.00 K(+1.5%) | $1.05 M(+16.7%) |
| Sep 2012 | - | $205.00 K(-50.0%) | $904.00 K(+1.5%) |
| Jun 2012 | - | $410.00 K(+76.7%) | $891.00 K(+24.8%) |
| Mar 2012 | - | $232.00 K(+307.0%) | $714.00 K(+7.9%) |
| Dec 2011 | $662.00 K(-12.9%) | $57.00 K(-70.3%) | $662.00 K(-14.1%) |
| Sep 2011 | - | $192.00 K(-17.6%) | $771.00 K(-7.9%) |
| Jun 2011 | - | $233.00 K(+29.4%) | $837.00 K(+1.2%) |
| Mar 2011 | - | $180.00 K(+8.4%) | $827.00 K(+8.8%) |
| Dec 2010 | $760.00 K(+16.6%) | $166.00 K(-35.7%) | $760.00 K(-5.7%) |
| Sep 2010 | - | $258.00 K(+15.7%) | $806.00 K(+2.9%) |
| Jun 2010 | - | $223.00 K(+97.3%) | $783.00 K(+12.2%) |
| Mar 2010 | - | $113.00 K(-46.7%) | $698.00 K(+7.1%) |
| Dec 2009 | $652.00 K(-38.1%) | $212.00 K(-9.8%) | $652.00 K(-2.2%) |
| Sep 2009 | - | $235.00 K(+70.3%) | $667.00 K(+7.2%) |
| Jun 2009 | - | $138.00 K(+106.0%) | $622.00 K(-22.3%) |
| Mar 2009 | - | $67.00 K(-70.5%) | $801.00 K(-23.9%) |
| Dec 2008 | $1.05 M(-40.9%) | $227.00 K(+19.5%) | $1.05 M(+8.8%) |
| Sep 2008 | - | $190.00 K(-40.1%) | $968.00 K(-25.3%) |
| Jun 2008 | - | $317.00 K(-0.6%) | $1.30 M(-4.5%) |
| Mar 2008 | - | $319.00 K(+124.6%) | $1.36 M(-23.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $1.78 M(+13.9%) | $142.00 K(-72.6%) | $1.78 M(-24.1%) |
| Sep 2007 | - | $518.00 K(+37.0%) | $2.35 M(+5.9%) |
| Jun 2007 | - | $378.00 K(-49.2%) | $2.22 M(+7.2%) |
| Mar 2007 | - | $744.00 K(+4.9%) | $2.07 M(+32.3%) |
| Dec 2006 | $1.56 M(-11.8%) | $709.00 K(+83.2%) | $1.56 M(+58.9%) |
| Sep 2006 | - | $387.00 K(+69.0%) | $984.00 K(-21.0%) |
| Jun 2006 | - | $229.00 K(-4.2%) | $1.25 M(-13.2%) |
| Mar 2006 | - | $239.00 K(+85.3%) | $1.43 M(-19.2%) |
| Dec 2005 | $1.77 M(-81.2%) | $129.00 K(-80.1%) | $1.77 M(-76.6%) |
| Sep 2005 | - | $648.00 K(+55.0%) | $7.57 M(-26.3%) |
| Jun 2005 | - | $418.00 K(-27.8%) | $10.27 M(+14.3%) |
| Mar 2005 | - | $579.00 K(-90.2%) | $8.99 M(-4.6%) |
| Dec 2004 | $9.42 M(-34.8%) | $5.92 M(+76.8%) | $9.42 M(-44.1%) |
| Sep 2004 | - | $3.35 M(-488.2%) | $16.85 M(+27.3%) |
| Jun 2004 | - | -$863.00 K(-185.1%) | $13.23 M(+4.0%) |
| Mar 2004 | - | $1.01 M(-92.4%) | $12.72 M(-12.0%) |
| Dec 2003 | $14.46 M(+1169.4%) | $13.35 M(-5106.3%) | $14.46 M(+874.2%) |
| Sep 2003 | - | -$266.60 K(-80.6%) | $1.48 M(-38.5%) |
| Jun 2003 | - | -$1.37 M(-149.9%) | $2.41 M(-37.8%) |
| Mar 2003 | - | $2.75 M(+637.9%) | $3.88 M(+240.7%) |
| Dec 2002 | $1.14 M(-43.2%) | $372.80 K(-43.6%) | $1.14 M(+13.2%) |
| Sep 2002 | - | $660.90 K(+592.0%) | $1.01 M(+42.0%) |
| Jun 2002 | - | $95.50 K(+874.5%) | $708.70 K(-36.8%) |
| Mar 2002 | - | $9800.00(-95.9%) | $1.12 M(-44.1%) |
| Dec 2001 | $2.00 M(+52.2%) | $240.40 K(-33.8%) | $2.00 M(+2.9%) |
| Sep 2001 | - | $363.00 K(-28.5%) | $1.95 M(+5.9%) |
| Jun 2001 | - | $507.60 K(-43.2%) | $1.84 M(+12.6%) |
| Mar 2001 | - | $893.80 K(+385.0%) | $1.63 M(+24.0%) |
| Dec 2000 | $1.32 M(+229.4%) | $184.30 K(-27.5%) | $1.32 M(-1.2%) |
| Sep 2000 | - | $254.30 K(-15.5%) | $1.33 M(+23.6%) |
| Jun 2000 | - | $301.10 K(-47.9%) | $1.08 M(+22.9%) |
| Mar 2000 | - | $577.80 K(+188.9%) | $877.80 K(+119.4%) |
| Dec 1999 | $400.00 K(0.0%) | $200.00 K(>+9900.0%) | $400.00 K(+100.0%) |
| Sep 1999 | - | $0.00(-100.0%) | $200.00 K(0.0%) |
| Jun 1999 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1999 | - | $100.00 K(>+9900.0%) | $100.00 K(-75.0%) |
| Dec 1997 | $400.00 K(-60.0%) | $0.00(-100.0%) | $400.00 K(+33.3%) |
| Sep 1997 | - | $100.00 K(>+9900.0%) | $300.00 K(-50.0%) |
| Jun 1997 | - | $0.00(-100.0%) | $600.00 K(-53.8%) |
| Mar 1997 | - | $300.00 K(-400.0%) | $1.30 M(+30.0%) |
| Dec 1996 | $1.00 M(+150.0%) | -$100.00 K(-125.0%) | $1.00 M(-33.3%) |
| Sep 1996 | - | $400.00 K(-42.9%) | $1.50 M(+36.4%) |
| Jun 1996 | - | $700.00 K(+75.0%) | $1.10 M(+175.0%) |
| Dec 1995 | $400.00 K(-20.0%) | $400.00 K(-500.0%) | $400.00 K(+33.3%) |
| Jun 1995 | - | -$100.00 K(-200.0%) | $300.00 K(-40.0%) |
| Mar 1995 | - | $100.00 K(-150.0%) | $500.00 K(0.0%) |
| Dec 1994 | $500.00 K(+400.0%) | -$200.00 K(-140.0%) | $500.00 K(-16.7%) |
| Sep 1994 | - | $500.00 K(+400.0%) | $600.00 K(+500.0%) |
| Jun 1994 | - | $100.00 K(0.0%) | $100.00 K(-50.0%) |
| Mar 1994 | - | $100.00 K(-200.0%) | $200.00 K(+100.0%) |
| Dec 1993 | $100.00 K(0.0%) | -$100.00 K(<-9900.0%) | $100.00 K(-50.0%) |
| Sep 1993 | - | $0.00(-100.0%) | $200.00 K(0.0%) |
| Jun 1993 | - | $200.00 K | $200.00 K |
| Dec 1992 | $100.00 K(0.0%) | - | - |
| Dec 1991 | $100.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for Fresh Tracks Therapeutics?
- What is the all time high quarterly CAPEX for Fresh Tracks Therapeutics?
- What is the all time high TTM CAPEX for Fresh Tracks Therapeutics?
What is the all time high annual CAPEX for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual capital expenditures is $14.46 M
What is the all time high quarterly CAPEX for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly capital expenditures is $13.35 M
What is the all time high TTM CAPEX for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM capital expenditures is $16.85 M